Diabetes Medications and Heart Failure Recognizing the Risk

被引：20

作者：

Fonarow, Gregg C. ^{[1
]}

机构：

[1] Ronald Reagan UCLA Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90095 USA

来源：

CIRCULATION | 2014年 / 130卷 / 18期

关键词：

Editorials; diabetes mellitus; heart failure; hospitalization; treatment outcome; MYOCARDIAL DIASTOLIC FUNCTION; GLYCEMIC CONTROL; GLUCOSE CONTROL; TYPE-2; INHIBITORS; PERFUSION; MELLITUS; OUTCOMES; TRIAL;

D O I：

10.1161/CIRCULATIONAHA.114.012883

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1565 / 1567

页数：3

共 20 条

[1] Dipeptidyl Peptidase-4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow-Mediated Vasodilatation in Type 2 Diabetic Patients [J].

Ayaori, Makoto ;

Iwakami, Naotsugu ;

Uto-Kondo, Harumi ;

Sato, Hiroki ;

Sasaki, Makoto ;

Komatsu, Tomohiro ;

Iizuka, Maki ;

Takiguchi, Shunichi ;

Yakushiji, Emi ;

Nakaya, Kazuhiro ;

Yogo, Makiko ;

Ogura, Masatsune ;

Takase, Bonpei ;

Murakami, Takehiko ;

Ikewaki, Katsunori .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (01) :e003277

[2] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[3] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes [J].

Duckworth, William ;

Abraira, Carlos ;

Moritz, Thomas ;

Reda, Domenic ;

Emanuele, Nicholas ;

Reaven, Peter D. ;

Zieve, Franklin J. ;

Marks, Jennifer ;

Davis, Stephen N. ;

Hayward, Rodney ;

Warren, Stuart R. ;

Goldman, Steven ;

McCarren, Madeline ;

Vitek, Mary Ellen ;

Henderson, William G. ;

Huang, Grant D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) :129-U62

[4]

Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743

[5] Renal and Cardiac Effects of DPP-4 Inhibitors - from Preclinical Development to Clinical Research [J].

Hocher, Berthold ;

Reichetzeder, Christoph ;

Alter, Markus L. .

KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 36 (01) :65-84

[6] Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes [J].

Holman, Rury R. ;

Sourij, Harald ;

Califf, Robert M. .

LANCET, 2014, 383 (9933) :2008-2017

[7]

Iribarren C, 2001, CIRCULATION, V103, P2668

[8] A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes metlitus And Diastolic Dysfunction) study [J].

Jarnert, Christina ;

Landstedt-Hallin, Lena ;

Malmberg, Klas ;

Melcher, Anders ;

Ohrvik, John ;

Persson, Hans ;

Ryden, Lars .

EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (01) :39-47

[9] ROLE OF DIABETES IN CONGESTIVE HEART-FAILURE - FRAMINGHAM STUDY [J].

KANNEL, WB ;

HJORTLAND, M ;

CASTELLI, WP .

AMERICAN JOURNAL OF CARDIOLOGY, 1974, 34 (01) :29-34

[10]

McMurray J., 2013, HEART FAIL C 2013 MA

← 1 2 →